# The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia

> **NCT03461042** · PHASE4 · COMPLETED · sponsor: **Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan** · enrollment: 17 (actual)

## Conditions studied

- Chronic Insomnia

## Interventions

- **DRUG:** Ramelteon 8mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03461042
- **Lead sponsor:** Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-06
- **Primary completion:** 2019-07-31
- **Final completion:** 2020-03-16
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2024-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03461042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03461042, "The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03461042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*